Pharma firm Aurobindo Pharma today said it has received approval from Health Canada for introducing its Cefprozil tablets and Cefprozil powder for oral suspension as an antibiotic.
The company has received the approvals for its abbreviated new drug submission from Health Canada, Aurobindo Pharma said in a filing to the Bombay Stock Exchange.
Cefprozil tablets are available in strengths of 250 mg and 500 mg and Cefprozil powder for oral suspension is available in strengths of 125 mg/5ml and 250mg/5ml, the filing added.
With these approvals, Aurobindo now has 11 products approved by Health Canada, the filing added.
Health Canada is the federal department responsible for helping Canadians maintain and improve their health.
Shares of Aurobindo Pharma were trading at Rs 941.50 on the BSE, up 0.01 per cent from the previous close.
Top Section
Explore Business Standard